Laboratory Testing Before Initiating Contraception in Women with PCOS
Before starting contraception in a reproductive-age woman with PCOS, you must assess cardiometabolic risk factors through specific laboratory tests: fasting glucose or oral glucose tolerance test, lipid panel, and blood pressure measurement. 1
Essential Pre-Contraception Laboratory Tests
Metabolic Screening (Mandatory)
- Glucose assessment: Oral glucose tolerance test (OGTT) is recommended over fasting glucose alone 2
- Lipid panel: Screen for dyslipidemia
- Blood pressure: Document baseline hypertension risk
These tests are critical because women with PCOS have twice the risk of metabolic syndrome compared to the general population and are four times more likely to develop type 2 diabetes 3. The 2013 Endocrine Society guideline specifically recommends preconceptual assessment of BMI, blood pressure, and oral glucose tolerance due to increased pregnancy complications in PCOS 2.
Risk Stratification Parameters to Document
Beyond laboratory tests, you must record:
- Age (VTE risk increases with age)
- Smoking status (contraindication for combined oral contraceptives)
- BMI/obesity status (increases VTE risk)
- Personal or family history of VTE
- Presence of thrombophilia (if clinically indicated)
Rationale: Why These Tests Matter
Combined oral contraceptives (COCs) are first-line therapy for PCOS management, but they carry increased risk of venous thromboembolism (VTE) related to both estrogen dose and progestin type 1. The cardiometabolic screening identifies patients at higher baseline risk who may need alternative contraceptive methods or closer monitoring.
Women with PCOS already have elevated metabolic risk, and COCs can potentially worsen glucose tolerance and lipid profiles in susceptible individuals. Individual risk assessment is the key to avoiding unfavorable outcomes 1.
Tests NOT Required Before Contraception Initiation
You do not need:
- Pelvic examination (unless placing IUD)
- Pap smear
- Clinical breast examination
- Routine chlamydia/gonorrhea screening (unless clinically indicated)
These represent unnecessary barriers to contraceptive access 4.
Common Pitfalls to Avoid
- Don't skip glucose screening: Even young, normal-weight women with PCOS can have glucose intolerance
- Don't use fasting glucose alone: OGTT is superior for detecting impaired glucose tolerance in PCOS 2
- Don't forget to reassess: Patients should be re-evaluated at consecutive visits, especially if baseline risk factors are present 1
- Don't require unnecessary examinations: Requiring pelvic exams or Pap smears before pill initiation creates barriers without improving safety 4
Clinical Algorithm
Step 1: Measure blood pressure in office
Step 2: Order laboratory tests:
- Oral glucose tolerance test (2-hour, 75g)
- Fasting lipid panel
Step 3: Document risk factors (age, smoking, BMI, family history VTE)
Step 4: If all parameters acceptable → proceed with COC prescription
Step 5: If metabolic abnormalities present → consider metformin first or alternative contraceptive methods (progestin-only, IUD)
This streamlined approach balances safety with accessibility, ensuring you identify high-risk patients while avoiding unnecessary barriers to contraceptive care.